{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:31:00Z","timestamp":1761906660827,"version":"build-2065373602"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"None"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Prostatic chronic inflammation has been found to be associated with prostate cancer risk. Caffeine intake has shown to exhibit anti-inflammatory properties. The relationship between caffeine and prostatic inflammation remains not known. We examined whether dietary intake and urinary concentration of caffeine and its metabolites are associated with serum prostate-specific antigen (PSA) levels, a surrogate marker of prostatic inflammation, among prostate cancer-free men.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cancer-free men, aged\u2009\u2265\u200940\u00a0years, with dietary caffeine intake and serum PSA results were identified from the 2001\u20132010 National Health and Nutrition Examination Survey. Elevated serum PSA was based on age- and race-specific definitions. Weighted logistic regression analysis with survey sample weights was used to examine the association between dietary intake and urinary concentration of caffeine and its metabolites and elevated serum PSA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were 5,456 men included. Approximately 6.4% of them had an elevated serum PSA. Men with an elevated serum PSA (geometric mean: 63.4\u00a0mg) had statistically significantly lower dietary caffeine intake compared to men with a normal serum PSA (geometric mean: 80.9\u00a0mg) (\n                      <jats:italic>p<\/jats:italic>\n                      value\u2009&lt;\u20090.01). After adjusting for confounders, dietary caffeine intake and urinary caffeine and its metabolites concentrations were not statistically significantly associated with elevated serum PSA.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Men with elevated serum PSA had lower dietary caffeine intake compared to men with a normal serum PSA. However, dietary caffeine intake and urinary caffeine concentration were not associated with elevated serum PSA, after adjusting for confounders. Prospective studies that investigate relationships among caffeine intake and prostatic inflammation are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10552-025-02015-1","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T10:06:02Z","timestamp":1751450762000},"page":"1409-1416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between dietary intake and urinary concentrations of caffeine and caffeine metabolites and elevated serum prostate-specific antigen (PSA) among men at risk for prostate cancer"],"prefix":"10.1007","volume":"36","author":[{"given":"Hongke","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia C.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"2015_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P (2019) Epidemiology of prostate cancer. World J Oncol 10:63\u201389","journal-title":"World J Oncol"},{"key":"2015_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1146\/annurev-nutr-071816-064941","volume":"37","author":"G Grosso","year":"2017","unstructured":"Grosso G, Godos J, Galvano F, Giovannucci EL (2017) Coffee, caffeine, and health outcomes: an umbrella review. Annu Rev Nutr 37:131\u2013156","journal-title":"Annu Rev Nutr"},{"key":"2015_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.canep.2018.07.013","volume":"56","author":"R Arthur","year":"2018","unstructured":"Arthur R, Kirsh VA, Rohan TE (2018) Associations of coffee, tea and caffeine intake with risk of breast, endometrial and ovarian cancer among Canadian women. Cancer Epidemiol 56:75\u201382","journal-title":"Cancer Epidemiol"},{"key":"2015_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00394-016-1253-6","volume":"56","author":"S Caini","year":"2017","unstructured":"Caini S, Cattaruzza S, Bendinelli B et al (2017) Coffee, tea and caffeine intake and the risk of non-melanoma skin cancer: a review of the literature and meta-analysis. Eur J Nutr 56:1\u201312","journal-title":"Eur J Nutr"},{"key":"2015_CR5","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1080\/01635581.2018.1512638","volume":"70","author":"T Tamura","year":"2018","unstructured":"Tamura T, Wada K, Konishi K et al (2018) Coffee, green tea, and caffeine intake and liver cancer risk: a prospective cohort study. Nutr Cancer 70:1210\u20131216","journal-title":"Nutr Cancer"},{"key":"2015_CR6","doi-asserted-by":"publisher","first-page":"3254420","DOI":"10.1155\/2022\/3254420","volume":"2022","author":"J Montenegro","year":"2022","unstructured":"Montenegro J, Freitas-Silva O, Teodoro AJ (2022) Molecular mechanisms of coffee on prostate cancer prevention. Biomed Res Int 2022:3254420","journal-title":"Biomed Res Int"},{"key":"2015_CR7","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/ijgc-2018-000102","volume":"29","author":"F Shafiei","year":"2019","unstructured":"Shafiei F, Salari-Moghaddam A, Milajerdi A, Larijani B, Esmaillzadeh A (2019) Coffee and caffeine intake and risk of ovarian cancer: a systematic review and meta-analysis. Int J Gynecol Cancer 29:579\u2013584","journal-title":"Int J Gynecol Cancer"},{"key":"2015_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ijc.30720","volume":"141","author":"G Pounis","year":"2017","unstructured":"Pounis G, Tabolacci C, Costanzo S et al (2017) Reduction by coffee consumption of prostate cancer risk: evidence from the Moli-sani cohort and cellular models. Int J Cancer 141:72\u201382","journal-title":"Int J Cancer"},{"key":"2015_CR9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/carcin\/bgt482","volume":"35","author":"S Cao","year":"2014","unstructured":"Cao S, Liu L, Yin X, Wang Y, Liu J, Lu Z (2014) Coffee consumption and risk of prostate cancer: a meta-analysis of prospective cohort studies. Carcinogenesis 35:256\u2013261","journal-title":"Carcinogenesis"},{"key":"2015_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-038902","volume":"11","author":"X Chen","year":"2021","unstructured":"Chen X, Zhao Y, Tao Z, Wang K (2021) Coffee consumption and risk of prostate cancer: a systematic review and meta-analysis. BMJ Open 11:e038902","journal-title":"BMJ Open"},{"key":"2015_CR11","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/annonc\/mdt420","volume":"25","author":"A Discacciati","year":"2014","unstructured":"Discacciati A, Orsini N, Wolk A (2014) Coffee consumption and risk of nonaggressive, aggressive and fatal prostate cancer\u2014a dose-response meta-analysis. Ann Oncol 25:584\u2013591","journal-title":"Ann Oncol"},{"key":"2015_CR12","first-page":"559","volume":"4","author":"ML Slattery","year":"1993","unstructured":"Slattery ML, West DW (1993) Smoking, alcohol, coffee, tea, caffeine, and theobromine: risk of prostate cancer in Utah (United States). Cancer Causes Control 4:559\u2013563","journal-title":"Cancer Causes Control"},{"key":"2015_CR13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nrc2090","volume":"7","author":"AM De Marzo","year":"2007","unstructured":"De Marzo AM, Platz EA, Sutcliffe S et al (2007) Inflammation in prostate carcinogenesis. Nat Rev Cancer 7:256\u2013269","journal-title":"Nat Rev Cancer"},{"key":"2015_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/MOU.0000000000000128","volume":"25","author":"O Bratt","year":"2015","unstructured":"Bratt O, Lilja H (2015) Serum markers in prostate cancer detection. Curr Opin Urol 25:59\u201364","journal-title":"Curr Opin Urol"},{"key":"2015_CR15","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1001\/jama.289.20.2695","volume":"289","author":"JA Eastham","year":"2003","unstructured":"Eastham JA, Riedel E, Scardino PT et al (2003) Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations. JAMA 289:2695\u20132700","journal-title":"JAMA"},{"key":"2015_CR16","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/pcan.2015.19","volume":"18","author":"MH Umbehr","year":"2015","unstructured":"Umbehr MH, Gurel B, Murtola TJ et al (2015) Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer. Prostate Cancer Prostatic Dis 18:264\u2013269","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2015_CR17","unstructured":"Division UoWMCDoLMI. (2011) Laboratory Procedure Manual Free Prostate-Specific Antigen (PSA)"},{"key":"2015_CR18","first-page":"352","volume":"40","author":"BD Toora","year":"2002","unstructured":"Toora BD, Rajagopal G (2002) Measurement of creatinine by Jaffe\u2019s reaction\u2013determination of concentration of sodium hydroxide required for maximum color development in standard, urine and protein free filtrate of serum. Indian J Exp Biol 40:352\u2013354","journal-title":"Indian J Exp Biol"},{"key":"2015_CR19","unstructured":"CDC (2011) National Health and Nutrition Examination Survey Laboratory Procedure Manual: Creatinine In: NCHS, ed. Hyattsville, MD: Department of Health and Human Services"},{"key":"2015_CR20","unstructured":"CDC (2009) National Health and Nutrition Examination Survery (NHANES) Laboratory Procedures Manual"},{"key":"2015_CR21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/pros.22782","volume":"74","author":"AC McDonald","year":"2014","unstructured":"McDonald AC, Vira MA, Vidal AC, Gan W, Freedland SJ, Taioli E (2014) Association between systemic inflammatory markers and serum prostate-specific antigen in men without prostatic disease\u2014the 2001\u20132008 National Health and Nutrition Examination Survey. Prostate 74:561\u2013567","journal-title":"Prostate"},{"key":"2015_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tjem.2018.08.001","volume":"18","author":"H Akoglu","year":"2018","unstructured":"Akoglu H (2018) User\u2019s guide to correlation coefficients. Turk J Emerg Med 18:91\u201393","journal-title":"Turk J Emerg Med"},{"key":"2015_CR23","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.3390\/nu10111772","volume":"10","author":"CM Reyes","year":"2018","unstructured":"Reyes CM, Cornelis MC (2018) Caffeine in the diet: country-level consumption and guidelines. Nutrients 10:1772","journal-title":"Nutrients"},{"key":"2015_CR24","first-page":"30","volume":"6","author":"E Mart\u00ednez-Pinilla","year":"2015","unstructured":"Mart\u00ednez-Pinilla E, O\u00f1atibia-Astibia A, Franco R (2015) The relevance of theobromine for the beneficial effects of cocoa consumption. Front Pharmacol 6:30","journal-title":"Front Pharmacol"},{"key":"2015_CR25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/01635581.2013.877497","volume":"66","author":"N Sugimoto","year":"2014","unstructured":"Sugimoto N, Miwa S, Hitomi Y, Nakamura H, Tsuchiya H, Yachie A (2014) Theobromine, the primary methylxanthine found in theobroma cacao, prevents malignant glioblastoma proliferation by negatively regulating phosphodiesterase-4, extracellular signal-regulated kinase, akt\/mammalian target of rapamycin kinase, and nuclear factor-kappa B. Nutr Cancer 66:419\u2013423","journal-title":"Nutr Cancer"},{"key":"2015_CR26","doi-asserted-by":"publisher","first-page":"14365","DOI":"10.3390\/ijms232214365","volume":"23","author":"L Goya","year":"2022","unstructured":"Goya L, Kongor JE, de Pascual-Teresa S (2022) From cocoa to chocolate: effect of processing on flavanols and methylxanthines and their mechanisms of action. Int J Mol Sci 23:14365","journal-title":"Int J Mol Sci"},{"key":"2015_CR27","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/B978-0-12-816093-0.00024-0","volume-title":"Nutrition in the prevention and treatment of abdominal obesity","author":"GD Pimentel","year":"2019","unstructured":"Pimentel GD, Micheletti TO, Fernandes RC, Nehlig A (2019) Chapter 24\u2013coffee intake and obesity. In: Watson RR (ed) Nutrition in the prevention and treatment of abdominal obesity, 2nd edn. Academic Press, Cambridge, pp 329\u2013351","edition":"2"},{"key":"2015_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00213-013-3021-0","volume":"228","author":"MJ Baggott","year":"2013","unstructured":"Baggott MJ, Childs E, Hart AB et al (2013) Psychopharmacology of theobromine in healthy volunteers. Psychopharmacology 228:109\u2013118","journal-title":"Psychopharmacology"},{"key":"2015_CR29","first-page":"63","volume":"39","author":"M Gil","year":"1993","unstructured":"Gil M, Skopi\u0144ska-R\u00f3zewska E, Radomska D et al (1993) Effect of purinergic receptor antagonists suramin and theobromine on tumor-induced angiogenesis in BALB\/c mice. Folia Biol (Praha) 39:63\u201368","journal-title":"Folia Biol (Praha)"},{"key":"2015_CR30","doi-asserted-by":"publisher","first-page":"11855","DOI":"10.1038\/s41598-023-39126-1","volume":"13","author":"J Fan","year":"2023","unstructured":"Fan J, Yuan Y, Zhang X et al (2023) Association between urinary caffeine and caffeine metabolites and stroke in American adults: a cross-sectional study from the NHANES, 2009\u20132014. Sci Rep 13:11855","journal-title":"Sci Rep"},{"key":"2015_CR31","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1186\/s12888-022-04415-y","volume":"22","author":"X-y Li","year":"2022","unstructured":"Li X-y, Liu H, Zhang L-y, Yang X-t (2022) Association between dietary theobromine with depression: a population-based study. BMC Psychiatry 22:769","journal-title":"BMC Psychiatry"},{"key":"2015_CR32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fpsyt.2017.00080","volume":"8","author":"JL Temple","year":"2017","unstructured":"Temple JL, Bernard C, Lipshultz SE, Czachor JD, Westphal JA, Mestre MA (2017) The safety of ingested caffeine: a comprehensive review. Front Psychiatry 8:80","journal-title":"Front Psychiatry"},{"key":"2015_CR33","unstructured":"Institute of Medicine Committee on Military Nutrition R. (2001) Caffeine for the sustainment of mental task performance: formulations for military operations. Washington (DC): National Academies Press (US) Copyright 2001 by the National Academy of Sciences. All rights reserved"},{"key":"2015_CR34","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.3390\/nu11081947","volume":"11","author":"HJ Kim","year":"2019","unstructured":"Kim HJ, Choi MS, Rehman SU et al (2019) Determination of urinary caffeine metabolites as biomarkers for drug metabolic enzyme activities. Nutrients 11:1947","journal-title":"Nutrients"},{"key":"2015_CR35","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3945\/jn.114.205476","volume":"145","author":"ME Rybak","year":"2015","unstructured":"Rybak ME, Sternberg MR, Pao CI, Ahluwalia N, Pfeiffer CM (2015) Urine excretion of caffeine and select caffeine metabolites is common in the U.S. population and associated with caffeine intake. J Nutr 145:766\u2013774","journal-title":"J Nutr"},{"key":"2015_CR36","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3945\/jn.114.205476","volume":"145","author":"ME Rybak","year":"2015","unstructured":"Rybak ME, Sternberg MR, Pao C-I, Ahluwalia N, Pfeiffer CM (2015) Urine excretion of caffeine and select caffeine metabolites is common in the US population and associated with caffeine intake 1, 2, 3, 4. J Nutr 145:766\u2013774","journal-title":"J Nutr"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-025-02015-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-025-02015-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-025-02015-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:26:42Z","timestamp":1761906402000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-025-02015-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2015"],"URL":"https:\/\/doi.org\/10.1007\/s10552-025-02015-1","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"type":"print","value":"0957-5243"},{"type":"electronic","value":"1573-7225"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Alicia C. McDonald is a full-time employee of Merck Sharp & Dohme LLC., a subsidiary of Merck & Co., Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This is an observational study. This study was conducted according to the principles of the Declaration of Helsinki. All data were approved by the National Center for Health Statistics Research Ethics Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all study participants to participate in NHANES.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Human research participants provided informed consent for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}